Latest Distributions News

Middle Island Resources has initiated its first reverse circulation drilling campaign at the Bobija Project in western Serbia, aiming to unlock polymetallic gold, silver, copper, lead, and zinc mineralisation beneath a historic open pit mine. This drilling marks a key step in advancing the company’s strategic acquisition of Konstantin Resources and its foothold in a prolific mineral province.

360 Capital Group (ASX, TGP) has received a $0.31 per security unconditional takeover offer from TT Investments, with the Independent Board Committee unanimously recommending acceptance in the absence of a superior proposal. The offer, supported by an independent expert, provides a premium to recent trading prices and offers certainty of cash consideration.

Deep Yellow Limited’s recent drilling campaign at the S-Bend prospect near its flagship Tumas Project in Namibia confirms significant shallow uranium mineralisation, potentially extending the project’s lifespan beyond 30 years.

Marmota Limited reports exceptional high-grade gold intersections from its maiden drilling program at the Greenewood discovery in South Australia, with detailed 1-metre assays underway to refine the promising results.

Garda Property Group has announced its distribution components for the year ending June 2026, highlighting key tax elements and a total cash payout scheduled for mid-October.

Resonance Health reveals a robust growth strategy targeting $17 million revenue by FY26, powered by AI-enhanced medical imaging and global clinical trial services expansion.

Cedar Woods Properties has updated its dividend announcement for the six months ending June 2025, confirming a fully franked 19 cents per share payout and revealing key details on its Dividend Reinvestment and Bonus Security Plans.

Clime Investment Management has completed a $2.3 million placement and announced a bonus option issue, positioning itself for growth as the Australian wealth management sector consolidates.

Cryosite Limited reports a strong start to FY26 with a 22% revenue increase and a strategic warehouse acquisition that doubles capacity, positioning the company for sustained growth in clinical trial logistics.

INOVIQ Limited has launched an A$11.5 million capital raise to fast-track clinical validation and commercialization of its ovarian cancer screening test and advance its CAR-exosome therapeutic program targeting solid tumors.

Strickland Metals has reported multiple thick, high-grade gold intercepts at its Gradina Deposit within the Rogozna Project, reinforcing the deposit’s significant potential ahead of a maiden resource estimate due late 2025.

PYC Therapeutics has reported encouraging pre-clinical results for its RNA therapy candidate PYC-002 targeting Phelan-McDermid Syndrome, supporting plans to enter human trials in 2026. The data demonstrate safety, brain distribution, and gene expression restoration in key disease regions.